SCHEMBL16381877

SCHEMBL16381877

COc1ccc(C=O)c(ON)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.76
TRIM24 O15164 1/20 0.58
TYR P14679 1/20 0.58
TRIM33 Q9UPN9 1/20 0.58
CYP1A2 P05177 8/20 0.53
CYP1A1 P04798 6/20 0.53
CYP1B1 Q16678 6/20 0.53
ERN1 O75460 2/20 0.53
CYP2C19 P33261 2/20 0.50
LMNA P02545 1/20 0.50
CYP2C9 P11712 1/20 0.50
MAPT P10636 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NFE2L2 Q16236 2/20 0.47
KDM4E B2RXH2 2/20 0.47
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
CA12 O43570 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96291 0.86 ALDH1A1 (1.00) ALDH1A1TRIM24TYRTRIM33CYP1A2
Hydrochloric Acid SCHEMBL9456784 0.85 ALDH1A1 (0.96) ALDH1A1TRIM24TYRTRIM33CYP1A2
Formaldehyde SCHEMBL28854145 0.83 ALDH1A1 (0.92) ALDH1A1TRIM24TYRTRIM33CYP1A2
Ethylene SCHEMBL4914414 0.83 ALDH1A1 (0.92) ALDH1A1TRIM24TYRTRIM33CYP1A2
SCHEMBL13893722 0.81 ALDH1A1 (0.69) ALDH1A1TRIM24TYRTRIM33CYP1A2
SCHEMBL16111393 0.80 ALDH1A1 (0.73) ALDH1A1TRIM24TYRTRIM33CYP1A2
SCHEMBL16046208 0.79 ALDH1A1 (0.71) ALDH1A1TRIM24TYRTRIM33CYP1A2
SCHEMBL9055047 0.79 ALDH1A1 (0.71) ALDH1A1TRIM24TYRTRIM33CYP1A2
SCHEMBL31432460 0.79 ALDH1A1 (0.71) ALDH1A1TRIM24TYRTRIM33CYP1A2
SCHEMBL8447028 0.79 ALDH1A1 (0.71) ALDH1A1TRIM24TYRTRIM33CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2571503-B1 COMPOSITIONS AND THEIR USE IN TREATING NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS DANA FARBER CANCER INST INC (US) 2015-01-07 EP disclosed